Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

Abstract

SEVERAL viral and bacterial live recombinant vaccine vehicles are being developed to produce a new generation of vaccines against a broad spectrum of infectious diseases1. The human tuberculosis vaccine Mycobacterium bovis bacillus Calmette–Guerin (BCG)2 has features that make it a particularly attractive live recombinant vaccine vehicle. BCG and other mycobacteria are highly effective adjuvants, and the immune response to mycobacteria has been studied extensively. With nearly two billion immunizations, BCG has a long record of safe use in man3,4. It is one of the few vaccines that can be given at birth, it engenders long-lived immune responses with only a single dose, and there is a worldwide distribution network with experience in BCG vaccination. Recently developed molecular genetic tools and methods for mycobacteria have provided the means to introduce foreign genes into BCG5–8. Here we report that a variety of human immunodeficiency virus type 1 polypeptides can be expressed in BCG recombinants under the control of the mycobacterial hspTO promoter and that the foreign polypeptides produced in BCG can induce antibody and T-cell responses. These results demonstrate that BCG can be used as a live recombinant vaccine vehicle to induce immune responses to pathogen proteins produced by the bacillus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bloom, B. R. Nature 342, 115–120 (1989).

    Article  ADS  CAS  Google Scholar 

  2. Calmette, A., Guerin, C. & Weill-Halle, B. Bull. Acad. natn. Med (Paris) 91, 787–796 (1924).

    Google Scholar 

  3. Luelmo, F. Am. Rev. resp. Dis. 125, 70–72 (1982).

    CAS  PubMed  Google Scholar 

  4. Lotte, A. et al. Adv. Tuberc. Res. 21, 107–193 (1984).

    CAS  PubMed  Google Scholar 

  5. Jacobs, W. R. Jr, Truckman, R. & Bloom, B. R. Nature 327, 532–535 (1987).

    Article  ADS  CAS  Google Scholar 

  6. Snapper, S. B. et al. Proc natn Acad. Sci. U.S.A. 85, 6987–6991 (1988).

    Article  ADS  CAS  Google Scholar 

  7. Husson, R. N., James, B. E. & Young, R. A. J. Bact. 172, 519–524 (1990).

    Article  CAS  Google Scholar 

  8. Martin, C. et al. Nature 345, 739–743 (1990).

    Article  ADS  CAS  Google Scholar 

  9. Neidhardt, F. C. & VanBogelen, R. A. In Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology (eds Neidhardt, F. C., Ingraham, J. L., Low, K. B., Magasanik, B. & Schaechter, M.) 1654 (American Society for Microbiology, Washington, DC, 1987).

    Google Scholar 

  10. Buchmeier, N. A. & Heffron, F. Science 248, 730–732 (1990).

    Article  ADS  CAS  Google Scholar 

  11. Young, R. A. A. Rev. Immun 8, 401–420 (1990).

    Article  CAS  Google Scholar 

  12. Lamb, J. R. & Young, D. B. Molec biol. Med 7, 311–321 (1990).

    CAS  PubMed  Google Scholar 

  13. Kaufmann, S. H. E. Immun. Today 11, 129–136 (1990).

    Article  CAS  Google Scholar 

  14. Mosmann, T. R. & Coffmann, R. L. Adv. Immun. 46, 111–147 (1989).

    Article  CAS  Google Scholar 

  15. Swain, S. L., McKenzie, D. T., Weinberg, A. D. & Hancock, W. J. Immun. 141, 3445–3455 (1988).

    CAS  PubMed  Google Scholar 

  16. Mosmann, T. J. Immunol. Meth. 65, 55–63 (1983).

    Article  CAS  Google Scholar 

  17. Nagler-Anderson, C., Verret, C. R., Firmenich, A. A., Berne, M. & Eisen, H. N. J. Immun. 141, 3299–3305 (1988).

    CAS  PubMed  Google Scholar 

  18. Walker, B. D. in Techniques in HIV Research (eds Aldovini, A. & Walker, B. D.) 201–210 (Stockton, New York, 1990).

    Book  Google Scholar 

  19. Pierce, E., James, S. L., Heiny, S., Lanar, D. E. & Sher, A. Proc. natn. Acad. Sci. U.S.A. 85, 5678–5682 (1988).

    Article  ADS  Google Scholar 

  20. Desrosiers, R. C. et al. Proc. natn. Acad. Sci. U.S.A. 86, 6353–6357 (1989).

    Article  ADS  CAS  Google Scholar 

  21. Murphey-Corb, M. et al. Science 246, 1293–1297 (1989).

    Article  ADS  CAS  Google Scholar 

  22. Bloom, B. R. J. Immun 137, 1–10 (1986).

    Google Scholar 

  23. Wyler, D. J., Beller, D. I. & Sypek, J. P. J. Immun. 138, 1246–1249 (1987).

    CAS  PubMed  Google Scholar 

  24. Ratner, L. et al. Nature 313, 277–284 (1985).

    Article  ADS  CAS  Google Scholar 

  25. Fisher, A. G., Collati, E., Ratner, L., Gallo, R. C. & Wong-Staal, F. Nature 316, 262–265 (1985).

    Article  ADS  CAS  Google Scholar 

  26. Maniatis, T., Fritsch, E. F. & Sambrook, J. Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982).

    Google Scholar 

  27. Laemli, U. K. Nature 227, 680–685 (1970).

    Article  ADS  Google Scholar 

  28. Aldovini, A. & Young, R. A. J. Virol. 64, 1920–1926 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aldovini, A., Young, R. Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines. Nature 351, 479–482 (1991). https://doi.org/10.1038/351479a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/351479a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing